Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
12 December 2020 |
Main ID: |
NCT02523937 |
Date of registration:
|
13/08/2015 |
Prospective Registration:
|
Yes |
Primary sponsor: |
|
Public title:
|
Evaluation of Soluble Fibrin in Thrombosis Exclusion
FSET |
Scientific title:
|
Evaluation of Performances of Soluble Fibrin Assay in Exclusion of Pulmonary Embolism and Deep Venous Thrombosis |
Date of first enrolment:
|
September 2015 |
Target sample size:
|
863 |
Recruitment status: |
Completed |
URL:
|
https://clinicaltrials.gov/show/NCT02523937 |
Study type:
|
Observational |
Study design:
|
|
Phase:
|
|
|
Countries of recruitment
|
France
| | | | | | | |
Contacts
|
Name:
|
Geneviève Contant, PhD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Diagnostica Stago |
|
Name:
|
Isabelle Mahe, MD, PhD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Université of Paris 7 - Paris Diderot |
| |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- patients with non-opposition to participate in the evaluation,
- outpatients from Emergency or Internal Medicine Units,
- clinically suspected of PE or DVT.
Exclusion Criteria:
- patients under 18 years old,
- patients with opposition to participate in the evaluation,
- patients with contraindication to iodinated contrast media.
Age minimum:
18 Years
Age maximum:
N/A
Gender:
All
|
Health Condition(s) or Problem(s) studied
|
Deep Vein Thrombosis (DVT)
|
Pulmonary Embolism (PE)
|
Intervention(s)
|
Other: Soluble Fibrin
|
Primary Outcome(s)
|
Performances of the Soluble Fibrin Assay for the exclusion of PE and DVT
[Time Frame: 24 Months]
|
Secondary Outcome(s)
|
Threshold of the Soluble Fibrin assays for the exclusion of PE and DVT
[Time Frame: 24 Months]
|
Secondary ID(s)
|
FSET 2014-A00588-39
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|